Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

19.70
Delayed Data
As of Aug 17
 -0.70 / -3.43%
Today’s Change
9.80
Today|||52-Week Range
26.10
+27.92%
Year-to-Date

Today’s Trading

Previous close20.40
Today’s open20.40
Day’s range19.58 - 20.75
Volume315,728
Average volume (3 months)641,192
Market cap$566.3M
Dividend yield3.39%
Data as of 3:59pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)-28.44%
Earnings growth (this year)+36.82%
Earnings growth (next 5 years)+274.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales10,755.10
Price/Book6.66

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.05+0.45%
OTICOtonomy Inc-0.50-2.58%
VSARVersartis Inc-0.15-0.90%
LCILannett Company Inc-0.95-5.92%
Data as of 4:01pm ET, 08/17/2017

Financials

Next reporting dateNovember 16, 2017
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$29.0K
Annual profit (last year)-$111.6M
Net profit margin-384,951.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, COO, Director &
CMO
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts